The somatic NAHR burden did not vary by tumor type nor was it lower in tumors harboring biallelic pathogenic mutations in DNA repair genes, including frequently mutated homologous recombination pathway mediators (BRCA1, BRCA2, PALB2 and RAD51C). The gene discussed is BRCA1; the disease is neoplasm.